Starton Therapeutics (Starton Therapeutics) Additional Paid-In Capital : $9.77 Mil(As of Jun. 2023)

View and export this data going back to 2050. Start your Free Trial

What is Starton Therapeutics Additional Paid-In Capital?

Starton Therapeutics's quarterly additional paid-in capital increased from Dec. 2022 ($7.12 Mil) to Mar. 2023 ($8.45 Mil) and increased from Mar. 2023 ($8.45 Mil) to Jun. 2023 ($9.77 Mil).

Starton Therapeutics's annual additional paid-in capital increased from Mar. 2021 ($2.16 Mil) to Mar. 2022 ($4.57 Mil) and increased from Mar. 2022 ($4.57 Mil) to Mar. 2023 ($8.45 Mil).

Starton Therapeutics Additional Paid-In Capital Historical Data

The historical data trend for Starton Therapeutics's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starton Therapeutics Additional Paid-In Capital Chart

Starton Therapeutics Annual Data

Trend

Mar21

Mar22

Mar23

Additional Paid-In Capital

2.16

4.57

8.45

Starton Therapeutics Quarterly Data
	Mar21	Dec21	Mar22	Jun22	Dec22	Mar23	Jun23
Additional Paid-In Capital	Get a 7-Day Free Trial			4.57	-	7.12	8.45	9.77

Starton Therapeutics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Starton Therapeutics Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Starton Therapeutics's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Starton Therapeutics (Starton Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starton Therapeutics Inc (NAS:STA) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

215 College Road, Suite No.300, Paramus, NJ, USA, 07652

Website

https://www.startontx.com

Starton Therapeutics Inc is a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary continuous delivery technology, so people with cancer can receive continuous treatment to live better, and longer. Starton's proprietary continuous delivery technology can increase the efficacy of approved drugs, make them more tolerable, and expand their potential use.

Starton Therapeutics (Starton Therapeutics) Headlines

No Headlines